Mail

UK markets close in 44 minutes

FTSE 100
8,142.81
+63.95(+0.79%)
FTSE 250
19,832.61
+230.63(+1.18%)
AIM
755.86
+2.74(+0.36%)
GBP/EUR
1.1668
+0.0012(+0.10%)
GBP/USD
1.2479
-0.0032(-0.25%)
Bitcoin GBP
51,333.51
+433.12(+0.85%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Biogen Inc. (BIIB.MX)

Mexico - Mexico Delayed price. Currency in MXN

Add to watchlist

3,450.00

0.00

(0.00%)

As of 01:55PM CST. Market open.

Currency in MXN

Valuation measures⁴

Market cap (intra-day)	504.07B
Enterprise value	604.48B
Trailing P/E	25.22
Forward P/E	13.09
PEG ratio (5-yr expected)	6.21
Price/sales (ttm)	3.04
Price/book (mrq)	1.93
Enterprise value/revenue	62.56
Enterprise value/EBITDA	286.91

Trading information

Stock price history

Beta (5Y monthly)	-0.01
52-week change ³	-31.14%
S&P500 52-week change ³	21.08%
52-week high ³	5,557.95
52-week low ³	3,286.00
50-day moving average ³	3,664.42
200-day moving average ³	4,175.24

Share statistics

Avg vol (3-month) ³	73
Avg vol (10-day) ³	54
Shares outstanding ⁵	145.6M
Implied shares outstanding ⁶	145.87M
Float ⁸	145.05M
% held by insiders ¹	0.69%
% held by institutions ¹	92.73%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	12.07%
Operating margin (ttm)	27.28%

Management effectiveness

Return on assets (ttm)	4.86%
Return on equity (ttm)	8.05%

Income statement

Revenue (ttm)	9.66B
Revenue per share (ttm)	66.69
Quarterly revenue growth (yoy)	-7.00%
Gross profit (ttm)	N/A
EBITDA	2.52B
Net income avi to common (ttm)	1.17B
Diluted EPS (ttm)	136.97
Quarterly earnings growth (yoy)	1.40%

Balance sheet

Total cash (mrq)	1.07B
Total cash per share (mrq)	7.38
Total debt (mrq)	6.95B
Total debt/equity (mrq)	45.66%
Current ratio (mrq)	2.10
Book value per share (mrq)	104.49

Cash flow statement

Operating cash flow (ttm)	1.65B
Levered free cash flow (ttm)	899.92M